Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pharmacopuncture is Scopus-indexed (Q2, CiteScore 3.1), WoS ESCI, DOAJ. Published by Korean Pharmacopuncture Institute.
Checked against the index lists dated .
ISSN 2093-6966Verify ISSN ↗2234-6856Verify ISSN ↗
Publisher: Korean Pharmacopuncture Institute
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 43 / 115 | 63rd | Q2 |
| Pharmacology | 210 / 328 | 36th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q2, CiteScore 3.1.
Journal of Pharmacopuncture is Q2 in Complementary and Alternative Medicine (rank 43 of 115) and Q3 in Pharmacology (rank 210 of 328), by CiteScore 2025.
Journal of Pharmacopuncture is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.1, which places it in quartile Q2 at the 63rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.398, quartile Q2, with an H-index of 32.
Journal of Pharmacopuncture is published by Korean Pharmacopuncture Institute. Its print ISSN is 2093-6966 and its online ISSN is 2234-6856.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Pharmacopuncture has an h-index of 36 and a 2-year mean of 1.32 citations per paper (OpenAlex). Its Scopus CiteScore is 3.1, quartile Q2. On 2-year citations it ranks #46 of 109 Scopus journals in Complementary and Alternative Medicine.
Journal of Pharmacopuncture published 36 papers in 2025; its busiest recent year was 2022 with 42. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from South Korea (55.5%), India (9%) and Indonesia (6.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (2.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.